Shimizu T - Search Results

1

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.

Takahashi H, Kashima T, Nomizo Y, Muramoto N, Shimizu T, Nasu K, Kubota T, Kimura S, Echizen H. Takahashi H, et al. Among authors: shimizu t. Clin Pharmacol Ther. 1998 May;63(5):519-28. doi: 10.1016/S0009-9236(98)90103-5. Clin Pharmacol Ther. 1998. PMID: 9630825 Clinical Trial.

2

Behaviour of connectin (titin) and nebulin in skinned muscle fibres released after extreme stretch as revealed by immunoelectron microscopy.

Maruyama K, Matsuno A, Higuchi H, Shimaoka S, Kimura S, Shimizu T. Maruyama K, et al. Among authors: shimizu t. J Muscle Res Cell Motil. 1989 Oct;10(5):350-9. doi: 10.1007/BF01758431. J Muscle Res Cell Motil. 1989. PMID: 2687326

3

[Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].

Okada T, Takahashi H, Ogura M, Nakao T, Shimizu T. Okada T, et al. Among authors: shimizu t. Nihon Jinzo Gakkai Shi. 1996 Jan;38(1):46-51. Nihon Jinzo Gakkai Shi. 1996. PMID: 8855137 Japanese.

4

Role of intercellular contacts in generating an asymmetric mitotic apparatus in the Tubifex embryo.

Takahashi H, Shimizu T. Takahashi H, et al. Among authors: shimizu t. Dev Growth Differ. 1997 Jun;39(3):351-62. doi: 10.1046/j.1440-169x.1997.t01-2-00011.x. Dev Growth Differ. 1997. PMID: 9227902

5

Long-term effects of LTB4 antagonist on lipid induced renal injury.

Nakao A, Nosaka K, Ohishi N, Noiri E, Suzuki T, Taniguchi S, Seki G, Watanabe T, Kurokawa K, Shimizu T, Kimura S. Nakao A, et al. Among authors: shimizu t. Kidney Int Suppl. 1997 Dec;63:S236-8. Kidney Int Suppl. 1997. PMID: 9407469

6

Unequal cleavage in the early Tubifex embryo.

Shimizu T, Ishii R, Takahashi H. Shimizu T, et al. Dev Growth Differ. 1998 Jun;40(3):257-66. doi: 10.1046/j.1440-169x.1998.00001.x. Dev Growth Differ. 1998. PMID: 9639353 Review.

7

Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.

Takahashi H, Kashima T, Nomoto S, Iwade K, Tainaka H, Shimizu T, Nomizo Y, Muramoto N, Kimura S, Echizen H. Takahashi H, et al. Among authors: shimizu t. Pharmacogenetics. 1998 Oct;8(5):365-73. doi: 10.1097/00008571-199810000-00001. Pharmacogenetics. 1998. PMID: 9825828

8

Ubiquitous localization of leukotriene A4 hydrolase in the rat nephron.

Nakao A, Watanabe T, Ohishi N, Toda A, Asano K, Taniguchi S, Nosaka K, Noiri E, Suzuki T, Sakai T, Kurokawa K, Shimizu T, Kimura S. Nakao A, et al. Among authors: shimizu t. Kidney Int. 1999 Jan;55(1):100-8. doi: 10.1046/j.1523-1755.1999.00257.x. Kidney Int. 1999. PMID: 9893118 Free article.

9

Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats.

Takahashi H, Yoshimoto M, Higuchi H, Shimizu T, Hishikawa Y. Takahashi H, et al. Among authors: shimizu t. Eur Neuropsychopharmacol. 1999 Jun;9(4):317-21. doi: 10.1016/s0924-977x(98)00051-0. Eur Neuropsychopharmacol. 1999. PMID: 10422892

10

Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.

Takahashi H, Sato T, Shimoyama Y, Shioda N, Shimizu T, Kubo S, Tamura N, Tainaka H, Yasumori T, Echizen H. Takahashi H, et al. Among authors: shimizu t. Clin Pharmacol Ther. 1999 Dec;66(6):569-81. doi: 10.1053/cp.1999.v66.103378001. Clin Pharmacol Ther. 1999. PMID: 10613612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,187 results

Search Page